Alimera Sciences
ALIM
ALIM was delisted on the 13th of September, 2024.
39 hedge funds and large institutions have $25.6M invested in Alimera Sciences in 2018 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 8 increasing their positions, 7 reducing their positions, and 6 closing their positions.
14% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 7
9% less funds holding
Funds holding: 43 → 39 (-4)
29% less capital invested
Capital invested by funds: $35.9M → $25.6M (-$10.3M)
50% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 6
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RA
Royce & Associates
New York
|
+$117K |
| 2 |
Renaissance Technologies
New York
|
+$74.9K |
| 3 |
DMK
David M. Knott
|
+$63.1K |
| 4 |
VF
Virtu Financial
New York
|
+$30.2K |
| 5 |
BRWM
B. Riley Wealth Management
Memphis,
Tennessee
|
+$18.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$428K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$396K |
| 3 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$262K |
| 4 |
TSS
Two Sigma Securities
New York
|
-$26K |
| 5 |
BRF
B. Riley Financial
Los Angeles,
California
|
-$24.9K |
ALIM Hedge Fund Activity: Q4 2018 in Review
39 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Alimera Sciences (ALIM) for Q4 2018, worth a combined $25.6M — down 29% from $35.9M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of ALIM and 3 opened new positions — a net loss of 3 holders — while 7 trimmed existing stakes and 8 added.
The largest buyer was Royce & Associates, adding an estimated $117K. The largest seller was Stonepine Capital Management, cutting an estimated $428K.
- 39 institutional investors held Alimera Sciences (ALIM) as of Q4 2018, down from 43 in Q3 2018.
- Funds reported $25.6M of Alimera Sciences stock for Q4 2018, down 29% quarter-over-quarter.
- 3 funds opened new Alimera Sciences positions in Q4 2018 and 6 closed out, a net change of -3 holders.
- The largest Alimera Sciences buyer in Q4 2018 was Royce & Associates, an estimated $117K added.
- The largest Alimera Sciences seller in Q4 2018 was Stonepine Capital Management, an estimated $428K sold.
Based on aggregated 13F filings for Q4 2018.